Ultrasound of the Spleen Utilizing Low-energy (Diagnostic Level) Insonification.
NCT06934096
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
This is a three-cohort, randomized, double-blinded , sham-controlled, single-center, early feasibility research trial to determine whether organ-specific biologic effects on platelet activity and coagulation are achievable through selective ultrasound of the spleen utilizing low-energy (diagnostic-level) insonification. Group 1: Focused insonification at center of the spleen. Group 2: Prolonged duration insonification at center of the spleen Group 3: Prolonged duration insonification across the spleen.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Hemostasis
- Blood Biomarkers
- Ultrasound
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 18 to 50 years
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Northwell Health
- Last updated on ClinicalTrials.gov
- August 27, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
New York · 1
- Feinstein Institute for Medical Research · Manhasset, NY
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.